Article Text

Download PDFPDF
EMA issues guide to biosimilars in the EU

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

EMA issues guide to biosimilars in the EU

The European Medicines Agency (EMA) has issued a guide for health professionals on biosimilars.1 The objective of the guide, which is a joint initiative of the EMA and the European Commission, is to provide information on the science and regulation underpinning the use of biosimilars. It was developed in collaboration with EU scientific experts in response to requests from healthcare professionals.

In principle, biosimilars are the biological medicines equivalent of generic chemical medicines.2 However, chemical drugs are generally low molecular weight …

View Full Text